Home LiteratureArticle Details
PMID: 3514450 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.

Infection and immunity ·Vol. 52 ·No. 1 ·1986-04-00 ·Pages 1-5

Kozel TR, Pfrommer GS

Abstract

The complement system plays a key role in resistance to cryptococcosis. In the present study, we examined several factors that influence the binding of C3 cleavage fragments to Cryptococcus neoformans. Binding of C3 was determined by using normal human serum supplemented with 125I-labeled C3. Incubation of encapsulated cryptococci in 20% serum led to the binding of approximately 3.2 X 10(6) molecules of C3 to each cell. The binding of C3 was markedly inhibited by heating the serum at 56 degrees C for 30 min or by chelation of the serum with EDTA. Chelation of the serum with EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] reduced binding of C3 by 37%. These results indicated that activation of C3 cleavage fragments and their binding to C. neoformans was primarily dependent upon the alternative pathway. Bound C3 could be removed by incubation with 1.0 M hydroxylamine (pH 10) but not by incubation with 3.5 M NaSCN or with phosphate-buffered saline containing 0.1% sodium dodecyl sulfate. These results suggested that C3 fragments were bound to C. neoformans by ester bonds. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of C3 fragments eluted from the yeast showed the presence of protein bands consistent with the presence of iC3b. C3b was not detected on the yeast after incubation with serum for time intervals as short as 2.5 min, indicating a rapid conversion of cell-bound C3b to iC3b. These results indicate that iC3b is the ligand which most likely interacts with the phagocyte C3 receptors involved in the phagocytosis of C. neoformans.

MeSH Terms
Complement Activation Complement C3/metabolism Complement C3b/metabolism Complement Pathway, Alternative Cryptococcus/immunology Cryptococcus neoformans/immunology Humans Kinetics Molecular Weight Phagocytosis Receptors, Complement/metabolism
Chemicals
Complement C3 Receptors, Complement Complement C3b
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kozel T R
Pfrommer G S
References (26)
26 references, click to expand
  1. Immunofluorescence studies of reactions at the Cryptococcal capsule.
    J Infect Dis. 1968 Apr;118(2):215-29 PMID: 4870973
  2. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    J Exp Med. 1985 Jun 1;161(6):1414-31 PMID: 2409200
  3. C3 shunt activation in human serum chelated with EGTA.
    J Immunol. 1972 Oct;109(4):807-9 PMID: 4627510
  4. The role of late complement components and the alternate complement pathway in experimental cryptococcosis.
    Proc Soc Exp Biol Med. 1973 Oct 1;144(1):312-5 PMID: 4129497
  5. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    J Immunol. 1974 Jun;112(6):2260-70 PMID: 4596700
  6. Activation of the alternate pathway of human complements by rabbit cells.
    J Immunol. 1974 Jul;113(1):348-58 PMID: 4134064
  7. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
    Infect Immun. 1976 Jul;14(1):62-7 PMID: 780279
  8. Third component of human complement: purification from plasma and physicochemical characterization.
    Biochemistry. 1976 Oct 5;15(20):4513-21 PMID: 823964
  9. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  10. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
  11. The physiological breakdown of the third component of human complement.
    Mol Immunol. 1980 Jan;17(1):9-20 PMID: 7360115
  12. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
    Biochemistry. 1980 Sep 16;19(19):4471-8 PMID: 7407085
  13. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    J Exp Med. 1981 Sep 1;154(3):856-67 PMID: 6912277
  14. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
    Biochem J. 1981 Jan 1;193(1):129-41 PMID: 7305917
  15. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Biochem J. 1981 May 1;195(2):471-80 PMID: 7316962
  16. Binding reaction between the third human complement protein and small molecules.
    Biochemistry. 1981 Dec 22;20(26):7457-63 PMID: 7326238
  17. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
    J Infect Dis. 1982 Jun;145(6):870-4 PMID: 7045251
  18. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    J Exp Med. 1982 Jul 1;156(1):205-16 PMID: 6177820
  19. Binding of C3b proceeds by a transesterification reaction at the thiolester site.
    Nature. 1982 Jul 1;298(5869):72-5 PMID: 6806664
  20. Structural characterization of factor I mediated cleavage of the third component of complement.
    Biochemistry. 1982 Nov 9;21(23):5745-9 PMID: 6217832
  21. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    J Immunol. 1983 Jul;131(1):409-15 PMID: 6223077
  22. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
    J Immunol. 1983 Oct;131(4):1930-5 PMID: 6225800
  23. Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules.
    Infect Immun. 1983 Nov;42(2):594-8 PMID: 6642644
  24. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
    Infect Immun. 1984 Feb;43(2):574-9 PMID: 6363293
  25. The chemistry and biology of complement receptors.
    Springer Semin Immunopathol. 1984;7(2-3):221-49 PMID: 6238434
  26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1986-04-00
Pages
1-5
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC262188
Subset
IM
Grants
NIAID NIH HHS · AI14209 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com